The Role of Echocardiography
Cardiovascular disease is the leading cause of death worldwide, and echocardiograms play a critical role in its management by using ultrasound to visualize the heart’s structure and function.
40M
7M
$1.8B
US adults with
cardiovascular disease
echocardiograms performed
in the US every year
echocardiography
market value
Despite the extensive use of echocardiography, its full potential is stifled by the limitations of
century-old ultrasound technology. Patients must travel to specialized clinics with trained
operators, limiting accessibility, reducing compliance, and increasing costs.
Introducing the First Wearable Cardiac Ultrasound
Sonus is developing the first wearable echocardiogram using its proprietary Sonus Array Technology. This groundbreaking device has the potential to transform heart disease diagnosis and management by providing patients and providers with actionable insights.
Increased
Access
Automated monitoring reduces the need for hospital visits and reliance on skilled operators, thereby removing geographic and economic barriers to quality care.
AI-Driven Accuracy & Speed
Harnessing AI to deliver seamless auto-scanning and real-time analysis to identify subtle heart function patterns, leading to more accurate diagnoses.
Better Patient Outcomes
Regular monitoring and
screening of patients can alert
care providers of potential issues enabling timely intervention and better outcomes.
AI-powered ultrasound wearable
for autonomous on-demand echocardiography
The patient applies patch and activates device via digital app
Data is uploaded to the cloud where cardiac parameters are determined using AI
The healthcare provider reviews data and intervenes as necessary
Applications
With its AI-driven technology, the Sonus Ultrasound Patch will enable new standards in
remote monitoring and diagnostic precision across healthcare disciplines. Reach out to
learn more and explore collaboration opportunities on various use cases.
Congestive Heart Failure (CHF)
CHF is a chronic condition where the heart’s ability to fill with and pump blood deteriorates. Management of this condition is ideally suited to benefit from frequent remote monitoring using Sonus’s Ultrasound Patch. CHF is the first of many potential indications in development.
The development of wearable echocardiography technology, such as that being pioneered by Sonus, would be a significant advancement in cardiovascular care. By enabling remote access to cardiac ultrasound, this innovation could significantly expand accessibility, improve early detection, and enhance patient outcomes.
Dr. Theodore Abraham MD, FACE, FASE
President, American Society of Echocardiography
Director, UCSF Adult Cardiac Echocardiography Lab
Collaborators
